Generate Biomedicines, Inc. is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company was founded in 2018, and is headquartered in Somerville, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
312
Frequently Asked Questions
What is Market Cap of Generate Biomedicines Inc?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Generate Biomedicines Inc market cap is $2.05B.
What is the 52-week high for Generate Biomedicines Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Generate Biomedicines Inc 52 week high is $16.75 as of May 16, 2026.
What is the 52-week low for Generate Biomedicines Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Generate Biomedicines Inc 52 week low is $11.00 as of May 16, 2026.
What is Generate Biomedicines Inc stock price today?
Generate Biomedicines Inc stock price today is $16.00.
What was Generate Biomedicines Inc stock price yesterday?
Generate Biomedicines Inc stock price yesterday was $15.47.
What is the Price-to-Book ratio of Generate Biomedicines Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Generate Biomedicines Inc P/B ratio is 3.9842.
What is the 50-day moving average of Generate Biomedicines Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Generate Biomedicines Inc 50-day moving average is $12.91.
How many employees does Generate Biomedicines Inc have?